GiveWell Breastfeeding Grant Market Hits 97% on Manifold as Traders Pile In

A quiet charity-evaluation market just turned into one of the busiest bets on Manifold. A contract asking whether GiveWell will recommend a grant to support breastfeeding promotion before 2027 is priced at about 97% “Yes” as of September 29, 2026, and roughly 77% of its entire trading history changed hands in the past 24 hours. The trigger was not a fresh grant headline. It was traders realizing the outcome may already be settled by grants GiveWell put on the record back in 2024.

Google · Preferred Sources

Don't miss new tech stories on Google

Add Tech Insider once in the Google app and our stories appear in your news suggestions.

Add Now

The market at a glance

The contract lives on Manifold Markets, the play-money forecasting platform where users trade with a virtual currency called Mana rather than dollars. The question, created by Manifold figure Nathan Young, reads: “Will GiveWell recommend a grant to support breastfeeding promotion before 2027?”

As of September 29, 2026, the market sits near 97% implied probability of “Yes.” Manifold data shows 268 total trades across 66 holders. The sudden burst of activity, with the bulk of all-time volume concentrated in a single day, is what pushed this niche question into the spotlight. For a market that had traded thinly for most of its life, that concentration of volume is the signal worth explaining.

What the market is actually asking

GiveWell is a nonprofit charity evaluator that directs hundreds of millions of dollars a year toward programs it judges to be highly cost-effective at saving or improving lives. Breastfeeding promotion is one intervention area GiveWell has studied. Its published Breastfeeding Promotion Programs review describes the area as promising and notes that GiveWell “may investigate opportunities to potentially fund breastfeeding promotion in certain contexts.”

The Manifold contract resolves “Yes” if GiveWell recommends a grant supporting breastfeeding promotion, with resolution tied to GiveWell’s public grant records or an equivalent public statement. That wording is broad, and it matters, because the phrasing does not clearly require a brand-new recommendation made after the market opened.

The odds and what they imply

In a prediction market, the trading price of a “Yes” share is read as the crowd’s implied probability of the event. A price near 97% means traders collectively see the outcome as nearly certain. If you are new to reading these numbers, our explainer on implied probability walks through the conversion, and our primer on how prediction markets work covers the mechanics of pricing and settlement.

The important nuance here is that a 97% price on a play-money market is not the same signal as a 97% price on a regulated, real-money exchange. Manifold uses Mana, not cash, so the incentive to correct a mispricing is weaker than on venues that settle in dollars. That said, the direction of travel is unambiguous. Traders are betting the answer is “Yes,” and the recent volume suggests they think the case is now obvious.

What is driving the sudden move

The most supported explanation, based on the market’s own comment thread and GiveWell’s public grant pages, is not a new September 2026 announcement. There is no verifiable record of a fresh breastfeeding grant being unveiled in the past two weeks. Instead, the move looks like traders converging on the view that GiveWell has already recommended qualifying grants, and that the broad resolution language should count them.

What is driving the sudden move - GiveWell Breastfeeding Grant Market Hits 97% on Manifold as Traders Pile In
What is driving the sudden move

In other words, this is less a bet on a future event and more a re-reading of the resolution criteria against grants already documented on GiveWell’s website. Once a few traders pointed to those records, the price climbed toward near-certainty and volume spiked as others followed.

The grants already on the record

Two GiveWell grant recommendations sit at the center of the argument. Both are documented on GiveWell’s own site and both involve breastfeeding.

DateRecipientAmount (up to)Purpose
March 2024IRD Global$800,000Pilot of SMS reminders to promote exclusive breastfeeding across districts in Sindh, Pakistan
November 2024Dimagi$320,356Design of a Mother-Baby Wellness coaching program on the CommCare Connect platform, including breastfeeding counseling visits

The IRD Global grant page describes up to $800,000 to test two-way SMS reminders aimed at reducing non-exclusive breastfeeding among young infants. The Dimagi grant page records $320,356 to design and test a program whose pillars include six counseling visits for breastfeeding parents. Both fit the plain reading of “a grant to support breastfeeding promotion.”

Who and what is involved

Nathan Young is a well-known question author on Manifold and a recurring figure in the effective altruism forecasting community, which overlaps heavily with GiveWell’s donor base. That overlap helps explain why an obscure charity-evaluation question attracts informed traders in the first place. The audience reading GiveWell grant pages and the audience trading this market are close to the same people.

GiveWell itself has not commented on the market, and there is no indication it treats a play-money contract as relevant to its research process. The organization’s public materials continue to frame breastfeeding promotion as an area under investigation, noting it has not yet estimated room for more funding for the program.

The resolution ambiguity that still matters

Here is the catch. If the question means “has GiveWell ever recommended a breastfeeding-related grant,” the answer already appears to be “Yes” thanks to the 2024 recommendations. If the question is instead read as “will GiveWell recommend a new breastfeeding grant during the market’s life,” the evidence is far thinner. GiveWell is still researching the area and has not publicly announced a new recipient, amount, or timetable.

The resolution ambiguity that still matters - GiveWell Breastfeeding Grant Market Hits 97% on Manifold as Traders Pile In
The resolution ambiguity that still matters

Traders in the comments have flagged a further wrinkle. The IRD Global grant was reportedly ended early, in December 2024, which raises the question of whether a terminated grant still counts toward a “Yes.” The market creator reserved the right to clarify resolution criteria in the question’s early months. That kind of definitional risk is exactly why prediction-market prices can look overconfident while the underlying question remains genuinely contestable.

Why a tech and finance audience should care

This market is small, but it is a clean case study in something that recurs across forecasting venues, from Manifold to real-money exchanges: prices move on interpretation of resolution language, not only on world events. A 97% reading here reflects a documentation discovery, not breaking news. Traders who follow rate-setting contracts see the same dynamic when they parse the fine print on questions like Fed rate cut odds, where the precise wording of what resolves “Yes” can matter as much as the economics.

It also underlines the gap between play-money and real-money platforms. If you want the contrast, our Kalshi vs Polymarket comparison lays out how regulated, cash-settled markets differ from the free-form question design common on Manifold.

What to watch next

Three things would move this market or settle it. First, an explicit resolution note from the market creator clarifying whether the 2024 grants qualify and whether the terminated IRD Global grant counts. Second, any new GiveWell grant page or blog post naming a fresh breastfeeding recipient and amount, which would remove all ambiguity. Third, the market’s close date at the end of 2026, after which the question resolves one way or the other. Until then, expect the price to stay pinned near certainty while the definitional debate continues in the comments.

Frequently asked questions

Is real money at stake in this market?
No. Manifold is a play-money platform that uses a virtual currency called Mana. It is a forecasting tool, not a betting exchange settling in cash.

Has GiveWell actually funded breastfeeding promotion?
GiveWell’s public records show a March 2024 recommendation of up to $800,000 to IRD Global and a November 2024 recommendation of $320,356 to Dimagi, both involving breastfeeding. GiveWell has not estimated room for more funding for the broader program area.

Why did the price jump now if the grants are from 2024?
The most supported explanation is that traders recognized the existing grants satisfy the market’s broad wording and piled in, rather than any new grant being announced in the past two weeks.

Could the market still resolve “No”?
It is possible if the creator interprets the question as requiring a new grant during the market’s life, or rules that a terminated grant does not count. That definitional risk is why the outcome is not fully settled.

The Bottom Line

A Manifold contract on whether GiveWell will back breastfeeding promotion before 2027 is near 97% “Yes” as of September 29, 2026, with most of its volume traded in a single day. The surge reflects traders recognizing GiveWell’s documented 2024 grants to IRD Global and Dimagi, not a new announcement. The remaining uncertainty is definitional: whether those grants, one of them ended early, satisfy the resolution criteria.

Sources

Prediction markets carry risk and are not investment or betting advice. Market availability is restricted by jurisdiction: Polymarket is not available to US persons, while Kalshi is a CFTC-regulated US exchange. Manifold operates with play money. Age restrictions of 18+ or 21+ apply where relevant. If you or someone you know has a gambling problem, call 1-800-GAMBLER for help.

Related Coverage

Morgan Reeves

Morgan Reeves

Prediction Markets Editor

Morgan Reeves covers prediction markets, sports analytics, and decentralized forecasting platforms. Background in quantitative finance and behavioral economics. Tracks Kalshi, Polymarket, PredictIt, and emerging US-regulated event-contract platforms since 2022.

View all articles